---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-113915"
form_type: "8-K"
ticker: "FENC"
cik: "0001211583"
company_name: "FENNEC PHARMACEUTICALS INC."
filed_at: "2025-11-19T23:59:59+00:00"
generated_at: "2026-05-16T18:22:03.476596+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Fennec Pharmaceuticals redeems all convertible notes, now debt-free

## Summary
- Redeemed all remaining Petrichor convertible notes for $21.73M (principal $19.48M, accrued interest $305k, redemption fee $1.95M).
- Used proceeds from underwritten public offering and private placement closed Nov 17-18, 2025.
- Company has no outstanding debt after the redemption.
- Notes previously bore interest at prime rate plus 4.5% (floor 3.5%) and had maturity Aug 19, 2027.

## SEC filing metadata
- accession: 0001104659-25-113915
- form_type: 8-K
- ticker: FENC
- cik: 0001211583
- company_name: FENNEC PHARMACEUTICALS INC.
- filed_at: 2025-11-19T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1211583/000110465925113915/0001104659-25-113915-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1211583/000110465925113915/tm2531627d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-113915
- JSON: https://secwatch.observer/filing/0001104659-25-113915.json
- Plain text: https://secwatch.observer/filing/0001104659-25-113915.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.